Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Chioma, Uzoigwe"'
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(11-12)
Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is effective in patients with type 2 diabetes (T2D), but treatment discontinuation without new T2D therapy initiation may compromise outcomes.This retrospective cohort study (July 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d77b0e21e86060c04bf74cb4370ff5e
https://pubmed.ncbi.nlm.nih.gov/36239850
https://pubmed.ncbi.nlm.nih.gov/36239850
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care resource utilization and cost in adults with type 2 diabetes mellitus (T2DM) and myocardial infarction (MI) . Methods: We conducted a retrospective cohort study using the Optum® Clinformatics® Data Mart claims da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ef7d772b679ed81ad4d10a5917e10e
https://doi.org/10.2337/db22-891-p
https://doi.org/10.2337/db22-891-p
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care resource utilization and all-cause healthcare costs in adults with type 2 diabetes mellitus (T2DM) and stroke. Methods: Patients ≥ 18 years of age with T2DM, with or without incident stroke, were identified betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38f5bd66e392426b78806fa3e7a91942
https://doi.org/10.2337/db22-890-p
https://doi.org/10.2337/db22-890-p
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care utilization and cost in adults with type 2 diabetes mellitus (T2DM) and peripheral artery disease (PAD) . Methods: Patients ≥ 18 years of age with T2DM, with or without PAD, were identified between January 1, 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eddf97d9154a904f60b3a9343e07f49c
https://doi.org/10.2337/db22-903-p
https://doi.org/10.2337/db22-903-p
Publikováno v:
Diabetes Therapy
Introduction The superior efficacy and safety of semaglutide once-weekly (QW), compared with dulaglutide, liraglutide, or exenatide QW, have been demonstrated in the SUSTAIN trials. This study assessed treatment persistence and adherence to semagluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c373e5c34b2933132b99357afad63994
http://europepmc.org/articles/PMC8099966
http://europepmc.org/articles/PMC8099966
Autor:
Swapna Karkare, Carol Mahler Hamersky, Michael Radin, Chioma Uzoigwe, Mitch DeKoven, Cassie Holt, William H. Polonsky
Publikováno v:
Quality of Life Research
Purpose Five quality of life (QoL) domains are particularly important to patients with type 2 diabetes (T2D) using basal insulin—sense of physical well-being, sense of safety regarding hypoglycemia, sense of diabetes as burdensome, feelings of free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33aa14ce5794977f89c3247331e9ce7e
http://europepmc.org/articles/PMC8178133
http://europepmc.org/articles/PMC8178133
Publikováno v:
Clinical therapeutics. 43(5)
Purpose Patients managing type 2 diabetes mellitus (T2DM) often require combination therapy to meet their blood glucose control targets. With limited real-world evidence focused on the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9adb7e6a1785edf83c0ae2c7579c16a3
https://pubmed.ncbi.nlm.nih.gov/33785221
https://pubmed.ncbi.nlm.nih.gov/33785221
Publikováno v:
Diabetes. 69
Background: This study presents real-world evidence on effectiveness of sema OW in a large cohort of T2D patients. Methods: Claims and lab result data were used to identify T2D patients who initiated sema OW between 2/1/18 - 4/30/19 (index as first c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ec4fef067475e8485d9e6fcb56a1a3
https://doi.org/10.2337/db20-953-p
https://doi.org/10.2337/db20-953-p
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Purpose The prevalence of hypoglycemia in patients with diabetes mellitus is likely underreported, particularly with regard to non-severe episodes, and representative estimates require more detailed data than claims or typical electronic health recor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b724681a4b5ce95d8b76deffe3d012df
https://pubmed.ncbi.nlm.nih.gov/32612376
https://pubmed.ncbi.nlm.nih.gov/32612376
Autor:
Paul Petraro, Sze-Jung Wu, Xian Zhang, Chioma Uzoigwe-Smith, Michael Radin, Judith J. Stephenson
Publikováno v:
Journal of the Endocrine Society
BACKGROUND: Hypoglycemia is a common side effect of glucose-lowering therapy, especially insulin and sulfonylureas, which can lead to serious complications including death. The prevalence of hypoglycemia reported in observational studies has been low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c062e66fd0047991711f33339b13dc45
http://europepmc.org/articles/PMC6550670
http://europepmc.org/articles/PMC6550670